Report: LDT market to exceed $17B October 20, 2020 -- A new report from Kalorama Information estimates the market for laboratory-developed tests (LDTs) is currently valued at $12 billion, and this figure will grow to $17 billion by 2025. The COVID-19 pandemic is driving demand for new LDTs, even as regulatory agencies duel over how to regulate the tests Discuss
NIH, BARDA award $98.35M in COVID-19 testing contracts October 7, 2020 -- The U.S. National Institutes of Health (NIH), along with the Biomedical Advanced Research and Development Authority (BARDA), a U.S. federal health agency, has awarded $98.35 million in contracts for COVID-19 testing under the Rapid Acceleration of Diagnostics initiative.
Quidel gets EUA for combo flu, COVID-19 test October 6, 2020 -- Quidel has received a U.S. Food and Drug Administration emergency use authorization (EUA) for a rapid diagnostic that can simultaneously identify influenza A, influenza B, and the novel coronavirus.
LabCorp nabs EUA for new COVID-19 molecular test October 5, 2020 -- The U.S. Food and Drug Administration has awarded LabCorp emergency use authorization (EUA) for a new, high-throughput method that uses heat and technology to extract RNA from COVID-19 samples.
Urgent care centers earn over $400M from COVID-19 testing October 1, 2020 -- With approximately 10,000 urgent care locations across the country and more than three-fourths of the U.S. population residing within a 10-minute drive of one, the urgent care market is expected to grow, writes Bruce Carlson of Kalorama Information, a sister company of LabPulse.com. Discuss
Quadrant wins EUA for COVID-19 saliva test September 24, 2020 -- Quadrant Biosciences has received emergency use authorization (EUA) from the U.S. Food and Drug Administration for its Clarifi COVID-19 test kit.
BD seeks FDA OK to use more samples with HPV test September 23, 2020 -- Becton Dickinson (BD) has asked the U.S. Food and Drug Administration (FDA) to make the ThinPrep Pap Test PreservCyt solution vial an approved sample for its Onclarity HPV assay.
Hoth, GW partner to develop mobile COVID-19 test September 21, 2020 -- Clinical-stage biopharmaceutical company Hoth Therapeutics and George Washington University (GW) have partnered to create a device that allows health professionals to diagnose COVID-19 with a mobile device.